论文部分内容阅读
远古有文字记录的血管医学资料可回朔到2000多年以前,当时是以中医、中药和针灸为主要诊治血管疾病的手段。现代医学自18世纪末引入,至上世纪50年代初可进行一些动脉结扎和截肢类的手术。20世纪60年代以后,以我国断肢(指、趾)再植的成功及布加综合征治疗方面的创新标志着我国显微血管外科和血管外科的发展和领先水平。从20世纪90年代初始以微创法成功治疗创伤性动静脉瘘,后又以同法治愈腹主动脉瘤,并于20世纪90年代末开始用以治疗夹层动脉瘤并取得成功。近来细胞和分子水平的研究已经取得一些成果。展望前景,腔内治疗将被广泛地应用,其装置将获进一步改进。基因和药物涂层支架、组织工程技术将在血管外科中得到更广泛而有效地应用。
Ancient text records of vascular medicine can be back to the information back to 2000 years ago, was based on traditional Chinese medicine, traditional Chinese medicine and acupuncture as the main means of diagnosis and treatment of vascular disease. Modern medicine has been introduced since the end of the 18th century and some arterial ligation and amputation surgery can be carried out by the early 1950s. After the 1960s, the success of replantation of the severed limbs (fingers and toes) and the treatment of Budd-Chiari signifies the development and leading level of microvascular surgery and vascular surgery in our country. From the beginning of the 1990s to the successful treatment of traumatic arteriovenous fistula with minimally invasive method, and later with the same method to cure abdominal aortic aneurysm, and in the late 90s began to treat dissecting aneurysms and success. Recent research at the cellular and molecular level has yielded some results. Looking ahead, endovascular treatment will be widely used, the device will be further improved. Gene and drug-coated stents, tissue engineering technology will be more widely used in vascular surgery and effective.